Role of copper and manganese in prion disease progression

Gerda Mitteregger1, Stefan Korte, Mehdi Shakarami

  • 1Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Feodor-Lynen-Str. 23, D-81377 Munich, Germany.

Brain Research
|July 29, 2009
PubMed

Insights

Dietary copper levels impact prion disease progression. Low copper shortens survival time in scrapie-infected mice, while high copper delays onset and affects cellular prion protein (PrP(C)) levels and cleavage.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Prion Disease Research

Background:

  • Cellular prion protein (PrP(C)) is crucial in prion disease pathogenesis.
  • Alterations in brain copper and manganese levels are observed in prion diseases, but their role is unclear.

Purpose of the Study:

  • To investigate the role of copper and manganese in prion disease pathogenesis.
  • To determine the effect of dietary copper on prion disease progression and PrP(C) metabolism.

Main Methods:

  • Analysis of synaptosomes from scrapie-infected mice.
  • Dietary manipulation of copper and manganese levels in mice.
  • Assessment of PrP(C) levels, cleavage, and resistance to proteases.

Main Results:

  • Scrapie infection led to reduced copper and increased manganese in mouse synaptosomes.
  • Low copper diets shortened survival time; high copper diets delayed disease onset.
  • Enhanced copper diets increased full-length and misfolded PrP(C) levels.
  • A copper-rich/manganese-poor diet decreased PrP(C) cleavage in healthy mice.

Conclusions:

  • Brain copper content influences PrP(C) levels and cleavage properties.
  • Copper availability may affect PrP conversion by altering functional PrP(C) levels, impacting prion disease progression.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...